TAMI BUZZARD: Open Payments
NPI 1528067667 · OLEAN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$697 in 39 payments from 17 companies in 2025. Trend: 2023 $786 · 2024 $833 · 2025 $697
Food & beverage: $697
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 7 | $143 |
| AstraZeneca Pharmaceuticals LP | 5 | $81 |
| Boston Scientific Corporation | 3 | $52 |
| Novartis Pharmaceuticals Corporation | 3 | $51 |
| SCPHARMACEUTICALS INC. | 3 | $51 |
| Medtronic, Inc. | 3 | $51 |
| BridgeBio Pharma, Inc. | 2 | $40 |
| Amgen Inc. | 2 | $34 |
| Merck Sharp & Dohme LLC | 2 | $32 |
| E.R. Squibb & Sons, L.L.C. | 2 | $31 |
Products named: ELIQUIS, FARXIGA, VYNDAQEL, WATCHMAN, LEQVIO, FUROSCIX, Attruby, Repatha.
Industry payments across NY — which companies pay providers there.
